Details of failed studies cast pall on Novo Nordisk's GLP-1 as Alzheimer's treatment - Reuters

Reuters | Dec. 3, 2025, 8:05 p.m. | Original
Details of failed studies cast pall on Novo Nordisk's GLP-1 as Alzheimer's treatment Reuters
Pentagon review faults Hegseth over Signal messages on Yemen strikes, sources say - Reuters Asia markets mixed, sentiment tepid as Fed looms - Reuters